Loading...
MRT Inc.
6034.T•JPX
Healthcare
Medical - Healthcare Information Services
¥700.00
¥0.00(0.00%)
MRT Inc. (6034.T) Financial Performance & Income Statement Overview
Review MRT Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-22.96%
↓ 22.96%
Operating Income Growth
-109.62%
↓ 109.62%
Net Income Growth
-159.80%
↓ 159.80%
Operating Cash Flow Growth
360.64%
↑ 360.64%
Operating Margin
-3.30%
↓ 3.30%
Gross Margin
64.45%
↑ 64.45%
Net Profit Margin
-8.26%
↓ 8.26%
ROE
-7.77%
↓ 7.77%
ROIC
-2.68%
↓ 2.68%
MRT Inc. (6034.T) Income Statement & Financial Overview
Review MRT Inc.'s (6034.T) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $1.01B | $933.00M | $1.28B | $937.48M |
| Cost of Revenue | $338.00M | $351.00M | $379.18M | $361.08M |
| Gross Profit | $674.00M | $582.00M | $904.25M | $576.40M |
| Gross Profit Ratio | $0.67 | $0.62 | $0.70 | $0.61 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $719.00M | $714.00M | $719.78M | $676.88M |
| Operating Expenses | $720.00M | $713.00M | $704.39M | $679.34M |
| Total Costs & Expenses | $1.06B | $1.06B | $1.10B | $1.04B |
| Interest Income | $0.00 | $0.00 | $3.17M | $3.27M |
| Interest Expense | $0.00 | $0.00 | $1.41M | $1.46M |
| Depreciation & Amortization | $68.00M | $66.00M | $64.86M | $59.62M |
| EBITDA | -$16.00M | -$66.00M | $262.90M | -$40.06M |
| EBITDA Ratio | -$0.02 | -$0.07 | $0.20 | -$0.04 |
| Operating Income | -$46.00M | -$131.00M | $199.85M | -$102.94M |
| Operating Income Ratio | -$0.05 | -$0.14 | $0.16 | -$0.11 |
| Other Income/Expenses (Net) | -$41.56M | -$7.00M | -$3.22M | -$5.06M |
| Income Before Tax | -$87.56M | -$138.00M | $196.64M | -$108.92M |
| Income Before Tax Ratio | -$0.09 | -$0.15 | $0.15 | -$0.12 |
| Income Tax Expense | -$28.36M | $21.00M | $88.17M | -$35.11M |
| Net Income | -$245.00M | -$96.00M | $98.98M | -$66.51M |
| Net Income Ratio | -$0.24 | -$0.10 | $0.08 | -$0.07 |
| EPS | -$44.28 | -$17.71 | $18.18 | -$12.22 |
| Diluted EPS | -$44.28 | -$17.63 | $18.17 | -$12.22 |
| Weighted Avg Shares Outstanding | $5.53M | $5.42M | $5.44M | $5.44M |
| Weighted Avg Shares Outstanding (Diluted) | $5.53M | $5.45M | $5.45M | $5.44M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan